Increased fluorodeoxyglucose uptake following endovascular abdominal aortic aneurysm repair: A predictor of endoleak?

Open Cardiovascular Medicine Journal

Volumn 4, Issue , 2010, Pages 117-119

  Paraskevas, Kosmas I ^a   Tzovaras, Alexandros A ^b   Stathopoulos, Vassilios ^c   Gentimi, Fotini ^d   Mikhailidis, Dimitri P ^e  

^a RED CROSS HOSPITAL   (Greece)

^b Agios Savvas Cancer Hospital   (Greece)

^c General Hospital of Rhodes   (Greece)

^d AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^e ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Abdominal aortic aneurysm; Endoleak; Endovascular aneurysm repair; Fluorodeoxyglucose; Predictor; Rupture risk

Indexed keywords

FLUORODEOXYGLUCOSE;

ABDOMINAL AORTA ANEURYSM; ANEURYSM RUPTURE; ANEURYSM SURGERY; ARTICLE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DIGITAL SUBTRACTION ANGIOGRAPHY; DRUG UPTAKE; ECHOGRAPHY; ENDOLEAK; ENDOVASCULAR SURGERY; HUMAN; INTERMETHOD COMPARISON; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 78249271393     PISSN: None     EISSN: 18741924     Source Type: Journal    
DOI: 10.2174/1874192401004010117     Document Type: Article

References (37)

1. Hirsch AT, Haskal ZJ, Hertzer NR, et al; American Association for Vascular Surgery, 2006; 113: e463-654
2. Hirsch AT, Haskal ZJ, Hertzer NR, et al; Society for Vascular Surgery, 2006; 113: e463-654.
3. Hirsch AT, Haskal ZJ, Hertzer NR, et al; Society for Car diovascular Angiography and Interventions, 2006; 113: e463-654
4. Hirsch AT, Haskal ZJ, Hertzer NR, et al; Society for Vascular Medicine and Biology, 2006; 113: e463-654.
5. Hirsch AT, Haskal ZJ, Hertzer NR, et al; Society of Interventional Radiology, 2006; 113: e463-654.
6. Hirsch AT, Haskal ZJ, Hertzer NR, et al; ACC/AHA Task Force on Practice Guidelines Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease, 2006; 113: e463-654.
7. Hirsch AT, Haskal ZJ, Hertzer NR, et al; American Association of Cardiovascular and Pulmonary Rehabilitation, 2006; 113: e463-654.
8. Hirsch AT, Haskal ZJ, Hertzer NR, et al; National Heart, Lung, and Blood Institute, 2006; 113: e463-654.
9. Hirsch AT, Haskal ZJ, Hertzer NR, et al; Society for Vascular Nursing, 2006; 113: e463-654.
10. Hirsch AT, Haskal ZJ, Hertzer NR, et al; TransAtlantic Inter-Society Consensus, 2006; 113: e463-654.
11. Hirsch AT, Haskal ZJ, Hertzer NR, et al; Vascular Disease Foundation, 2006; 113: e463-654.
12. Hirsch AT, Haskal ZJ, Hertzer NR, et al; Circulation 2006; 113: e463-654.
13. Fillinger M. Who should we operate on and how do we decide: predicting rupture risk and survival in patients with aortic aneurysm. Semin Vasc Surg 2007; 20: 121-127.
14. Reeps C, Essler M, Pelisek J, Seidl S, Eckstein HH, Krause BJ. Increased 18F-fluorodeoxyglucose uptake in abdominal aortic aneurysms in positron emission/computed tomography is associated with inflammation, aortic wall instability, and acute symptoms. J Vasc Surg 2008; 48: 417-423.
15. Tawakol A, Migrino RQ, Hoffmann U, et al. Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography. J Nucl Cardiol 2005; 12: 294-301.
16. Shimizu K, Mitchell RN, Libby P. Inflammation and cellular immune response in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 2006; 26: 987-994.
17. Sakalihasan N, Van Damme H, Gomez P, et al. Positron emission tomography (PET) evaluation of abdominal aortic aneurysm (AAA). Eur J Vasc Endovasc Surg 2002; 23: 431-436.
18. Sakalihasan N, Hustinx R, Limet R. Contribution of PET scanning to the evaluation of abdominal aortic aneurysm. Semin Vasc Surg 2004; 17: 144-153.
19. Truijers M, Kurvers HA, Bredie SJ, Oyen WJ, Blankensteijn JD. In vivo imaging of abdominal aortic aneurysms: increased FDG up-take suggests inflammation in the aneurysm wall. J Endovasc Ther 2008; 15: 462-467.
20. Paraskevas KI. Regarding "Increased 18F-fluorodeoxyglucose uptake in abdominal aortic aneurysms in positron emission/computed tomography is associated with inflammation, aortic wall instability, and acute symptoms". J Vasc Surg 2009; 49: 1631.
21. Harris PL, Vallabhaneni SR, Desgranges P, Becquemin JP, van Marrewijk C, Laheij RJ. Incidence and risk factors of late rupture, conversion, and death after endovascular repair of infrarenal aortic aneurysms: the EUROSTAR experience. European Collaborators on Stent/graft techniques for aortic aneurysm repair. J Vasc Surg 2000; 32: 739-749.
22. Bernhard VM, Mitchell RS, Matsumura JS, et al. Ruptured abdominal aortic aneurysm after endovascular repair. J Vasc Surg 2002; 35: 1155-1162.
23. Schlosser FJ, Gusberg RJ, Dardik A, et al. Aneurysm rupture after EVAR: can the ultimate failure be predicted? Eur J Vasc Endovasc Surg 2009; 37: 15-22.
24. Stavropoulos SW, Charagundla SR. Imaging techniques and management of endoleaks after endovascular aortic aneurysm repair. Radiology 2007; 243: 641-655.
25. Kranokpiraksa P, Kaufman JA. Follow-up of endovascular aneurysm repair: plain radiography, ultrasound, CT/CT angiography, MR imaging/MR angiography, or what? J Vasc Interv Radiol 2008; 19: S27-36.
26. Fransen GA, Vallabhaneni SR Sr, van Marrewijk CJ, Laheij RJ, Harris PL, Buth J; EUROSTAR. Rupture of infra-renal aortic aneurysm after endovascular repair: a series from EUROSTAR registry. Eur J Vasc Endovasc Surg 2003; 26: 487-493.
27. Faries PL, Briggs VL, Bernheim J, Kent KC, Hollier LH, Marin ML. Increased recognition of type II endoleaks using a modified intraoperative angiographic protocol: implications for intermittent endoleak and aneurysm expansion. Ann Vasc Surg 2003; 17: 608-614.
28. AbuRahma AF. Fate of endoleaks detected by CT angiography and missed by color duplex ultrasound in endovascular grafts for abdominal aortic aneurysms. J Endovasc Ther 2006; 13: 490-495.
29. Szmidt J, Galazka Z, Rowinski O, et al. Late aneurysm rupture after endovascular abdominal aneurysm repair. Interact Cardiovasc Thorac Surg 2007; 6: 490-494.
30. Zimmerman PM, Cherr GS, Angelo GC, Gona J, Dosluoglu HH. Is F 18 fluorodeoxyglucose positron emission tomography too sensitive for the diagnosis of vascular endograft infection? Vascular 2008; 16: 346-349.
31. Paraskevas KI, Liapis CD, Hamilton G, Mikhailidis DP. Are statins an option in the management of abdominal aortic aneurysms? Vasc Endovascular Surg 2008; 42: 128-134.
32. Paraskevas KI, Andrikopoulou M, Anastasakis E, Perrea D, Mikhailidis DP. Oxidative stress in the pathogenesis of abdominal aortic aneurysms: a possible pathway for the effect of statins? Angiology 2010; 61: 226-227.
33. Paraskevas KI, Liapis CD, Hamilton G, Mikhailidis DP. Can statins reduce perioperative morbidity and mortality in patients undergoing non-cardiac vascular surgery? Eur J Vasc Endovasc Surg 2006; 32: 286-293.
34. Paraskevas KI, Athyros VG, Briana DD, Kakafika AI, Karagiannis A, Mikhailidis DP. Statins exert multiple beneficial effects on patients undergoing percutaneous revascularization procedures. Curr Drug Targets 2007; 8: 942-951.
35. Schermerhorn ML, O'Malley AJ, Jhaveri A, Cotterill P, Pomposelli F, Landon BE. Endovascular vs. open repair of abdominal aortic aneurysms in the Medicare population. N Engl J Med 2008; 358: 464-474.
36. Cao P. CAESAR Trial Collaborators. Comparison of surveillance vs Aortic Endografting for Small Aneurysm Repair (CAESAR) trial: study design and progress. Eur J Vasc Endovasc Surg 2005; 30: 245-251.
37. Ouriel K. Treating smaller AAAs. Does the availability of endovascular grafts change the size threshold for repair? Endovascular Today 2005; 3: 39-42. Available at: http://www.evtoday.com/PDF articles/0305/F1_Ouriel.html.